Anglo American plc, facing a severe HIV/AIDS epidemic in South Africa, implemented a pioneering program to provide employees with free antiretroviral therapy (ART) in response to rising infection rates among its workforce. Although the initiative aimed to alleviate the epidemic's impact, it garnered mixed results with ongoing challenges including high treatment costs, nonadherence, and criticism from various stakeholders. As the company grapples with these complexities, it also encounters pressure to take a more active role in combating the epidemic, while the South African government remains uncooperative.